ACB vs CRON

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

ACB

33.4
AI Score
VS
ACB Wins

CRON

33.3
AI Score

Investment Advisor Scores

ACB

33score
Recommendation
EXTENDED

CRON

33score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric ACB CRON Winner
Forward P/E 109.8901 19.7628 CRON
PEG Ratio 0 0 Tie
Revenue Growth -8.8% 58.4% CRON
Earnings Growth -94.7% 126.8% CRON
Tradestie Score 33.4/100 33.3/100 ACB
Profit Margin -38.2% 39.1% CRON
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED SELL ACB

Relative Price Performance (Last 90 Days)

ACB 1M: +47.6% · 3M: +13.9% CRON 1M: +21.4% · 3M: +24.5%

Current Technical Phase

ACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 73.2 · Price: $3.94

CRON

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.6% over 20 days), RSI 73

RSI (14): 73.1 · Price: $3.41

Fundamentals Snapshot

Metric ACB CRON
Market Cap
Forward P/E -656.7 21.5
Trailing P/E 17.4
Revenue (TTM)
Revenue Growth -0.1% 0.6%
Gross Margin 0.4% 0.4%
Operating Margin -0.1% 0.2%
EPS -0.67 0.19
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ACB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.